Pharmaceutical Networks: The Political Economy of Drug Development in the United States, 1945–1980

Dominique A. Tobbell

Enterprise & Society, 2009, vol. 10, issue 4, 675-686

Abstract: Pharmaceutical Networks describes how American drug firms,biomedical researchers, physicians, and Congressional reformers shaped the research, regulatory, and policy environments for prescription drugs in the three decades after World War II. In these decades, pharmaceutical reformers in Congress sought to secure passage of legislation that would increase the government's control over drug development, distribution, and practice. They proposed these reforms as a way of curbing the high cost of prescription drugs and putting a break on the escalating health care costs. To defend itself against this reform movement, the American drug industry built alliances with research universities, medical schools, and professional medical societies by offering to the medical and academic communities solutions to their shared problems. These problems included a shortage of biomedical workers and the increasing authority of the government over medical practice.

Date: 2009
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.cambridge.org/core/product/identifier/ ... type/journal_article link to article abstract page (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cup:entsoc:v:10:y:2009:i:04:p:675-686_00

Access Statistics for this article

More articles in Enterprise & Society from Cambridge University Press Cambridge University Press, UPH, Shaftesbury Road, Cambridge CB2 8BS UK.
Bibliographic data for series maintained by Kirk Stebbing ().